You are here

Article Text

Article menu
Download PDFPDF
PostScript
Tribulations of stroke trials

https://doi.org/10.1136/neurintsurg-2013-010974

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests JPB is a principal investigator for the IMS III trial. JB receives drugs from Genentech for two ongoing NINDS studies and from Schoering-Plough for one NINDS study. TAT is a principal interventionist for the IMS III trial and Core Lab for Angiographic Procedures for the IMS III trial. TAT has received research grants from Core Lab ev3/Covidien for the Solitaire Retrospective Analysis, prior to device entry into the IMS III trial.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles

    • Editor's column
      The tribulations of stroke trials
      Felipe C Albuquerque David Fiorella Joshua A Hirsch Charles Prestigiacomo Robert W Tarr
      Journal of NeuroInterventional Surgery 2013; 5 181-183 Published Online First: 08 Apr 2013. doi: 10.1136/neurintsurg-2013-010731
    • PostScript
      Tribulations of stroke trials
      Felipe C Albuquerque David Fiorella Joshua A Hirsch Charles Pretigiacomo Robert W Tarr
      Journal of NeuroInterventional Surgery 2013; 8 e13-e14 Published Online First: 07 Oct 2013. doi: 10.1136/neurintsurg-2013-010978